Use the Search Fields to Find Information
Page 73 of 332
Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA
Please use this link to access this publication. Abstract The legality of cannabis use has been changing in a number of jurisdictions around the world. In the
May 16, 2025
PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program
Background: New Mexico was the first state to list post-traumatic stress disorder (PTSD) as a condition for the use of medical cannabis. There are no
September 19, 2019
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program
Abstract Background: New Mexico was the first state to list post-traumatic stress disorder (PTSD) as a condition for the use of medical cannabis. There are
August 16, 2023
Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review
Please use this link to access this publication. Abstract Cannabis is the most widely used illicit drug worldwide, and it is estimated that up to
June 20, 2025
Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis: A Double-Blind, Placebo Controlled, Crossover Study
Abstract Objectives: To study possible psychopathological symptoms and cognitive deficits, abuse induction, as well as general tolerability and effects on quality of life, fatigue and motor
September 19, 2019
Psychoneuroendocrinological links between chronic stress and depression
Abstract Objective: The goal of this report is to develop a comprehensive model, which integrates psychosocial and neurobiological aspects, for better understanding the link between
August 23, 2023
Psychoactive Drugs Like Cannabis -Induce Hypodopaminergic Anhedonia and Neuropsychological Dysfunction in Humans: Putative Induction of Dopamine Homeostasis via Coupling of Genetic Addiction Risk Severity (GARS) testing and Precision Pro-dopamine Regulation (KB220)
Abstract Many US states now embrace the medical and recreational use of Cannabis. Changes in the laws have heightened interest and encouraged research into both
May 20, 2024
Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)
Abstract The endocannabinoid system (ECS) acts as a negative feedback mechanism to suppress synaptic transmission and plays a major role in a diverse range of
August 30, 2025
Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain
Abstract Cannabinoid CB2 receptor (CB2) agonists are potential analgesics void of psychotropic effects. Peripheral immune cells, neurons and glia express CB2; however, the involvement of CB2 from
September 19, 2025
Protective effects of Δ9-tetrahydrocannabinol against N-methyl-Daspartate-induced AF5 cell death
The neuroprotective effects of Δ 9 -tetrahydrocannabinol (THC) were examined using an in vitro model in which the AF5 CNS cell line was exposed to
September 19, 2019
Page 73 of 332